𝔖 Bobbio Scriptorium
✦   LIBER   ✦

5180813 Early envelope glycoprotein of human cytomegalovirus (HMCV) and monoclonal antibodies to the glycoproteins


Book ID
103118797
Publisher
Elsevier Science
Year
1993
Tongue
English
Weight
95 KB
Volume
25
Category
Article
ISSN
0020-711X

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Isolation and characterization of human
✍ da Silva Cardoso, Marcia; Siemoneit, Karl; Sturm, Daniela; Krone, Christoph; Mor πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 590 KB

The isolation and characterization of human monoclonal antibodies (humAbs) against the hepatitis C Virus (HCV) glycoproteins E1 and E2 are described. B-cells from blood donors with anti-HCV were transformed with Epstein-Barr virus. The supernatants of the resulting lymphoblastoid clones were screene

Production and characterisation of a hum
✍ S. Sutherland; D. H. Crawford; S. A. Wilson; B. Morgan; T. Azim; E. R. Huehns πŸ“‚ Article πŸ“… 1987 πŸ› John Wiley and Sons 🌐 English βš– 674 KB

A human monoclonal antibody to cytomegalovirus (CMV) was produced by transforming peripheral blood mononuclear cells of a patient with recent CMV infection. It is directed against a late antigen located in the nucleus of CMV infected fibroblasts at 24-72 hours postinfection and immuneprecipitates 65

Monoclonal antibody to a human leukocyte
✍ Rosemarie Dalchau; Jean Kirkley; John W. Fabre πŸ“‚ Article πŸ“… 1980 πŸ› John Wiley and Sons 🌐 English βš– 972 KB

## Abstract The monoclonal antibody (F10–89–4) described in this study recognizes an antigen which by quantitative absorption analysis is absent from human brain, kidney, liver, heart, erythrocytes, platelets and normal serum, but is present on spleen, lymph node, chronic lymphatic leukemia cells,

Human monoclonal antibodies that react w
✍ Darren J. Schofield; Birke Bartosch; Yohko K. Shimizu; Tobias Allander; Harvey J πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 187 KB

Active and/or passive immunoprophylaxis against hepatitis C virus (HCV) remain unachieved goals. Monoclonal antibodies might provide one approach to protection. We derived human monoclonal antibodies from the bone marrow of a patient with a well-controlled HCV infection of 22 years duration. Five di